Can‑Fite BioPharma Insider Buying Signals Long‑Term Confidence & Patent Growth
Investor insight: Can‑Fite BioPharma’s steady insider option holdings and recent obesity patent suggest long‑term confidence, offering potential upside amid volatile market conditions.
5 minutes to read